SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 103 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,063,512 | +23.7% | 1,107,825 | -3.3% | 0.00% | – |
| Q1 2023 | $859,589 | +83.4% | 1,146,119 | -9.9% | 0.00% | – |
| Q4 2022 | $468,617 | -27.9% | 1,271,687 | -15.9% | 0.00% | – |
| Q3 2022 | $650,000 | -53.2% | 1,512,589 | -15.2% | 0.00% | – |
| Q2 2022 | $1,390,000 | -35.0% | 1,783,093 | +7.6% | 0.00% | – |
| Q1 2022 | $2,137,000 | -38.8% | 1,657,272 | -39.7% | 0.00% | – |
| Q4 2021 | $3,490,000 | -6.8% | 2,748,299 | +60.1% | 0.00% | -100.0% |
| Q3 2021 | $3,743,000 | -60.2% | 1,716,550 | -31.6% | 0.00% | 0.0% |
| Q2 2021 | $9,413,000 | +136.4% | 2,510,343 | +105.5% | 0.00% | 0.0% |
| Q1 2021 | $3,981,000 | +26.3% | 1,221,340 | +32.2% | 0.00% | – |
| Q4 2020 | $3,151,000 | +97.3% | 924,166 | +136.3% | 0.00% | – |
| Q3 2020 | $1,597,000 | -67.4% | 391,069 | -73.0% | 0.00% | -100.0% |
| Q2 2020 | $4,903,000 | -43.8% | 1,450,592 | -61.3% | 0.00% | -50.0% |
| Q1 2020 | $8,725,000 | +130.9% | 3,744,519 | +260.8% | 0.00% | +100.0% |
| Q4 2019 | $3,778,000 | -15.7% | 1,037,965 | +92.2% | 0.00% | 0.0% |
| Q3 2019 | $4,480,000 | -45.5% | 540,107 | -43.4% | 0.00% | -50.0% |
| Q2 2019 | $8,223,000 | +138.4% | 955,000 | +195.9% | 0.00% | +100.0% |
| Q1 2019 | $3,449,000 | -39.2% | 322,697 | -50.2% | 0.00% | -50.0% |
| Q4 2018 | $5,675,000 | +30.9% | 648,507 | +151.3% | 0.00% | +100.0% |
| Q3 2018 | $4,336,000 | -33.4% | 258,083 | -16.8% | 0.00% | -50.0% |
| Q2 2018 | $6,506,000 | +99.4% | 310,365 | +53.0% | 0.00% | +100.0% |
| Q1 2018 | $3,262,000 | -28.9% | 202,801 | -16.2% | 0.00% | 0.0% |
| Q4 2017 | $4,589,000 | -0.7% | 242,128 | -26.3% | 0.00% | 0.0% |
| Q3 2017 | $4,622,000 | +258.0% | 328,504 | +89.6% | 0.00% | – |
| Q2 2017 | $1,291,000 | -46.2% | 173,288 | -53.1% | 0.00% | – |
| Q1 2017 | $2,400,000 | -1.2% | 369,298 | -32.7% | 0.00% | – |
| Q4 2016 | $2,430,000 | +335.5% | 548,610 | +359.2% | 0.00% | – |
| Q3 2016 | $558,000 | -71.5% | 119,462 | -59.9% | 0.00% | -100.0% |
| Q2 2016 | $1,958,000 | +557.0% | 298,150 | +535.5% | 0.00% | – |
| Q1 2016 | $298,000 | +86.2% | 46,918 | +77.1% | 0.00% | – |
| Q4 2015 | $160,000 | -88.4% | 26,490 | -88.5% | 0.00% | -100.0% |
| Q3 2015 | $1,381,000 | +513.8% | 230,927 | +601.7% | 0.00% | – |
| Q2 2015 | $225,000 | -79.7% | 32,911 | -82.0% | 0.00% | – |
| Q1 2015 | $1,111,000 | -71.5% | 183,160 | -67.4% | 0.00% | -100.0% |
| Q4 2014 | $3,895,000 | +229.8% | 562,061 | +287.7% | 0.00% | – |
| Q3 2014 | $1,181,000 | +9.1% | 144,967 | +9.0% | 0.00% | – |
| Q2 2014 | $1,082,000 | +277.0% | 133,038 | +262.0% | 0.00% | – |
| Q1 2014 | $287,000 | -91.8% | 36,751 | -90.7% | 0.00% | -100.0% |
| Q4 2013 | $3,498,000 | +8.0% | 395,215 | +2.3% | 0.00% | -50.0% |
| Q3 2013 | $3,238,000 | -33.8% | 386,308 | -41.0% | 0.00% | 0.0% |
| Q2 2013 | $4,888,000 | – | 655,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,020,583 | $15,053,000 | 1.77% |
| Piermont Capital Management Inc. | 247,882 | $1,847,000 | 0.53% |
| BARD ASSOCIATES INC | 129,380 | $964,000 | 0.44% |
| Sonora Investment Management, LLC | 239,202 | $1,782,055,000 | 0.34% |
| TFS CAPITAL LLC | 97,526 | $727,000 | 0.28% |
| Alambic Investment Management, L.P. | 165,001 | $1,229,000 | 0.15% |
| KENNEDY CAPITAL MANAGEMENT LLC | 491,075 | $3,659,000 | 0.07% |
| Renaissance Technologies | 6,071,817 | $45,235,000 | 0.06% |
| Granite Investment Partners, LLC | 97,023 | $723,000 | 0.05% |
| ClariVest Asset Management LLC | 241,909 | $1,802,000 | 0.04% |